The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA-based genomic profiling of small bowel adenocarcinoma.
 
Pat Gulhati
No Relationships to Disclose
 
Karan Pandya
No Relationships to Disclose
 
Hiba I. Dada
Employment - Gilead Sciences (I); Guardant Health; Illumina
Stock and Other Ownership Interests - Gilead Sciences (I); Guardant Health; Illumina
 
Christopher R. Cogle
No Relationships to Disclose
 
Jason S. Starr
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - Ipsen; Natera; Pfizer
Research Funding - Incyte (Inst); Macrogenics (Inst); Merus (Inst); Molecular Templates (Inst); Natera; Rafael Pharmaceuticals (Inst); Vedanta Biosciences (Inst)
 
Sujith R. Kalmadi
Employment - ironwood cancer and research centers
Stock and Other Ownership Interests - AstraZeneca; Immunomedics
Consulting or Advisory Role - Abbvie/Genentech; AstraZeneca/MedImmune; Bayer; EMD Serono; Lilly
Speakers' Bureau - AstraZeneca/MedImmune; Bayer; Genentech/Roche; Novartis/Pfizer; Pharmacyclics/Janssen; takeda
Research Funding - Abbvie/Genentech; Genentech/Roche; Novocure; Pfizer/EMD Serono; tesaro
 
Fadi S. Braiteh
Honoraria - Amgen; ARIAD; Astellas Pharma; AstraZeneca; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Daiichi Sankyo/Lilly; Genentech/Roche; Gilead Sciences; Guardant Health; Immunomedics; Incyte; Ipsen; Lexicon; Lilly; Puma Biotechnology; Regeneron; Sanofi/Aventis; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Coherus Biosciences; Daiichi Sankyo/Lilly; Deciphera; Eisai; Exelixis; Genentech/Roche; Guardant Health; Immunomedics; Incyte; Ipsen; Lilly; Merck; Merck; Merck; Pfizer; Regeneron; Sanofi; Taiho Oncology; Taiho Oncology; Takeda
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Incyte; Insys Therapeutics; Ipsen; Lilly; Merck; Merck; Merrimack; Pfizer; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; AstraZeneca/MedImmune; Bayer; Bayer/Onyx; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Exelixis; HERON; Incyte; Insys Therapeutics; Ipsen; Lexicon; Merrimack; Novartis; Pfizer; Regeneron; Roche/Genentech; Sanofi; Taiho Pharmaceutical; Tesaro
 
Leylah Drusbosky
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Travel, Accommodations, Expenses - Guardant Health